Document is current
Any future updates will be listed below
-
Authors
Cain, Anael
Taga, Mariko
McCabe, Cristin
Green, Gilad S.
Hekselman, Idan
White, Charles C.
Lee, Dylan I. https://orcid.org/0000-0002-0349-6131
Gaur, Pallavi https://orcid.org/0000-0002-0286-1950
Rozenblatt-Rosen, Orit
Zhang, Feng https://orcid.org/0000-0003-0178-7995
Yeger-Lotem, Esti https://orcid.org/0000-0002-8279-7898
Bennett, David A.
Yang, Hyun-Sik https://orcid.org/0000-0002-8318-0443
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Menon, Vilas https://orcid.org/0000-0002-4096-8601
Habib, Naomi https://orcid.org/0000-0002-6049-2487
De Jager, Philip L. https://orcid.org/0000-0002-8057-2505
- License Information
-
More Information
Article History
Received: 23 December 2020
Accepted: 10 May 2023
First Online: 19 June 2023
Competing interests
: A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and until 31 August 2020 was an SAB member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and ThermoFisher Scientific. From 1 August 2020, A.R. is an employee of Genentech, a member of the Roche Group. The remaining authors declare no competing interests.
